Everolimus showed efficacy in reducing angiomyolipoma lesion volume in patients with SEGA associated with TSC.The trial is registered with ClinicalTrials.gov , number NCT00789828 ; http://clinicaltrials.gov/ct2/show/NCT00789828?term=EXIST-1&rank=1 .